Functional mechanisms including post-translational modifications of catalytic and regulatory PP2A subunits and aberrant expression of PP2A endogenous inhibitors SET, SETBP1 and CIP2A represent novel emerging mechanisms for PP2A regulation in cancer [18,19,53,54,109]. The gene discussed is PTPA; the disease is cancer.